EXHIBIT 10.1
VISX, Incorporated
0000 Xxxxxxx Xxxxxxxxxx
Xxxxx Xxxxx, XX 00000
March 12, 2002
Xx. Xxxxxx X. Xxxxxx
Chairman and Chief Executive Officer
Medjet Inc.
0000 Xxxx Xxxxxxx Xxxx Xxxx, Xxxxx 000
Xxxxxx, XX 00000
RE: RESEARCH, DEVELOPMENT AND EXPERIMENTAL COST SHARING AGREEMENT
Dear Xx. Xxxxxx:
I am writing in reference to the Research, Development and Experimental
Cost Sharing Agreement (the "R&D AGREEMENT"), dated as of August 17, 2001, by
and between VISX, Incorporated ("VISX") and Medjet Inc. ("MEDJET"). Capitalized
terms not otherwise defined in this letter shall have the meanings given to such
terms in the R&D Agreement.
This letter is to confirm the parties' understanding that the
$2,500,000 figure set forth in Section 1.2 of the R&D Agreement is not a cap on
VISX's expenditures pursuant to the R&D Agreement. Rather, the $2,500,000 figure
refers to the parties' estimate (at August 27, 2001) of what VISX's maximum
expenditure under the R&D Agreement would be.
Please indicate your agreement with the foregoing by signing the
enclosed counterpart of this letter and returning it to the undersigned.
Sincerely,
VISX, INCORPORATED
/S/ XXXXX X. XXXXXXXX
-------------------------------------------
Xxxxx X. Xxxxxxxx
Vice President, Controller
Agreed to and accepted.
MEDJET INC.
/S/ XXXXXX X. XXXXXX
----------------------------------
Xx. Xxxxxx X. Xxxxxx
Chairman and Chief Executive Officer
